CeGaT (Center for Genomics and Transcriptomics) GmbH, the Department of Prostate Cancer Research, Institute of Pathology, University Hospital Bonn and Genomatix Software GmbH were announced as finalist (Top 3) of the CLARITY challenge, organized by Boston Children’s Hospital.
The challenge was started in April 2012 by sending raw genome sequence data and medical records of three families (children and their immediate relatives) to 30 teams worldwide including BGI, NIH and other well-known genome centres. Two of the patients had undiagnosed neuromuscular diseases, the other a cardiovascular disorder. In all casescurrent diagnostic tests gave negative results. The aim of the CLARITY challenge was not only to solve the three cases but also to standardize methods for analyzing, interpreting, reporting and, ultimately, using genomic information in a clinical setting.
To achieve this, CeGaT and Genomatix Software successfully combined their expertise and services to solve the cases within the time limit given and identify best methods andpractices to provide meaningful results to medical doctors, patients and their families. The team was the only one to correctly flag every likely genetic mutation in all threefamilies.
CeGaT and Genomatix will now offer their complete genetic analysis service to another six families (six trios or 18 exomes) for free. The families will be selected on the basis of clinical manifestations with a yet unknown genetic cause. This free exomes project will build on the experiences gained in the CLARITY challenge and hopefully allow patients to find better treatment options by understanding the cause of their diseases. Its goal is to follow the CLARITY mission to improve the clinical relevance of genetic analysis in hospitals. Hospitals and doctors who are interested in registering patients for this projectwill find more information on the CeGaT website starting Nov 07, 2012.Genomatix announced the pre-release of geneGrid, a web application designed to help medical researchers identifying pathogenic genomic variations in humans. The GeneGrid technology allows one to annotate and filter thousands of genomic variations within seconds and is supported by a large body of medical and genomics data. In addition, GeneGrid is integrated with many established Genomatix tools, such as the Genomatix Pathway System (GePS) and the Genomatix Genome Browser.
For further information:CeGaT GmbHE-mail: info(at)cegat.dePhone: +49 7071 565 44 00